Two More Heartburn Meds Recalled Due to Possible Carcinogen

FRIDAY, Jan. 10, 2020 — The U.S. Food and Drug Administration is adding to a list of recalled lots of popular heartburn medications — including generic forms of Zantac — because the pills might contain small amounts of a suspected carcinogen.
Source: Topamax